Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 30 for your search:
Drug:
chlorozotocin
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-3278
2.
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7841
3.
Phase II-III Chemotherapy with MeGAG or CLZ or AMSA or CTX/VCR/MTX for Colorectal Adenocarcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-1277R
4.
Phase I/II Systemic Hyperthermia plus Chemotherapy with Chlorozotocin for Unresectable Refractory Adult Malignant Melanoma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 to 69
Sponsor:
Protocol IDs:
NCI-D81-043-374
5.
Phase II Chemotherapy with Chlorozotocin for Advanced Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MSKCC-7793
6.
Phase II Chlorozotocin for Carcinoma of the Breast and Ovary, Melanoma, Islet Cell Carcinoma, Lymphoma, Sarcoma, and Other Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
NCI-78-C-97
, NCI-MB-8402
7.
Phase II Adjuvant Chemotherapy with CLZ, TZT, CACP, or BCNU/5-FU for Intracranial Neoplasms
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
over 15
Sponsor:
Protocol IDs:
BTSG-7820
8.
Phase II Study of CLZ and PRED in the Treatment of Refractory Multiple Myeloma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-80MM265
9.
Phase II Chemotherapy with Chlorozotocin for Small Cell, Large Cell, Adenocarcinoma of Lung
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7832
10.
Phase II Chemotherapy with Chlorozotocin for Adenocarcinoma of the Colon, Pancreas, Liver, or Stomach
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7833
11.
Phase II Chemotherapy with Chlorozotocin for Surgically Incurable Islet Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7935
12.
Phase II Chemotherapy with Chlorozotocin for Advanced Sarcoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7982
13.
Phase II Chemotherapy with Chlorozotocin for Advanced Carcinoma of Breast, Colon, Malignant Melanoma, Lymphoma, Sarcoma and Others
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
WSU-C-25077
14.
Phase II Chemotherapy with 5-FU/CLZ in Patients with Inoperable Refractory Islet Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-8208
15.
Phase II Chemotherapy with Chlorozotocin for Melanoma, Lymphoma, and Advanced Gastrointestinal, Pancreatic, Lung, and Breast Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7772
16.
Pilot Phase II Study of Chlorozotocin for Multiple Myeloma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7801
17.
Phase II Chemotherapy with Chlorozotocin for Advanced Soft Tissue Sarcoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
15 to 75
Sponsor:
NCI
Protocol IDs:
EORTC-62791
18.
Master Protocol for Phase II Chemotherapy for Advanced Soft-Tissue and Bone Sarcomas and Mesotheliomas --- BLEO vs CLZ vs MGBG vs Bruceantin
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
14 to 75
Sponsor:
NCI
Protocol IDs:
EST-1379
19.
Phase II Master Protocol with MeCCNU, MeCCNU/BCG, MeCCNU/HU/DTIC, BCG, ACT-D/HU/DTIC, CLZ, NZS, MGBG, or DBD Therapy for Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-1675
20.
Phase II Master Protocol and Chemotherapy with cis-Platinum, Maytansine, or Chlorozotocin for Advanced Small Cell Bronchogenic Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-2578
21.
Phase II Chemotherapy with Chlorozotocin for Advanced, Recurrent and Metastatic Pelvic Malignancies in Progression
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-26K
22.
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- CLZ, FAM (5-FU/ADR/MITO), SAM (SZC/ADR/MeCCNU), CACP
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
GITSG-9376C
23.
Phase II Study of Chlorozotocin for Advanced Malignant Disease
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
GUMC-9
24.
Phase II Chemotherapy with Maytansine or Chlorozotocin for Advanced Breast Cancer with Crossover Upon Progression
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-773202
25.
Phase II Chemotherapy with Maytansine or Chlorozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-777001B
Select All on Page
1
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
